Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Acquisitions and Emerging Markets Key to Medical Device Industry

By HospiMedica International staff writers
Posted on 18 Apr 2011
The medical device market should see significant growth over the next few years as a result of emerging markets, an aging population, and increased acquisitions. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent market research firm.

Medical device companies saw growth in 2010 despite a slow economy and pressure on pricing, and that growth should continue for the next few years, according to report. Bellwether medical device companies grew at an average of 6% in 2010, on the higher side of most growth estimates a year ago, and Kalorama Information predict that the US$305 billion medical device market should see growth continue in that range over the next few years. Many market leaders chose 2010 to make strategic moves, by either divesting unprofitable areas or acquiring areas that were in line with strategic goals, and where cross-selling opportunities were present.

The medical device market, however, was not without challenges during these moves, including regulatory procedures, group-purchasing negotiations, and a new tax that was introduced as part of US healthcare reform. However, the report pointed to a robust amount of merger and acquisition activity in the market as an indication that the medical device industry is optimistic about the future. Among the acquisitions that occurred during 2010 was the acquisition of endovascular company ev3 (Plymouth, MN, USA) by Covidien (Dublin, Ireland) for $2.6 billion. Orthopedic giant Stryker (Kalamazoo, MI, USA) purchased the neurovascular unit of Boston Scientific, and Baxter Healthcare assumed bone graft maker Apatech (Deerfield, IL, USA). Medtronic acquired several companies, including spinal neuromodulation products manufacturer Axon Systems, heart valve maker ATS Medical and Invatec, a producer of stents.

"It's a healthy sign that so many of the top companies chose 2010 to make strategic moves," said report author Bruce Carlson, publisher of Kalorama Information. "In some categories, such as orthopedics or respiratory, it's simple demographics and improved economics in the developed world that led to growth. For most companies, double-digit growth in orders to India, China, Brazil, and other nations fueled revenues."

Related Links:
Kalorama Information
ev3
Covidien
Stryker
Apatech


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.